SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 749.88 |
| Enterprise Value ($M) | 597.52 |
| Book Value ($M) | 838.86 |
| Book Value / Share | 5.01 |
| Price / Book | 0.89 |
| NCAV ($M) | 773.88 |
| NCAV / Share | 4.62 |
| Price / NCAV | 0.97 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.39 |
| Return on Assets (ROA) | -0.41 |
| Return on Equity (ROE) | -0.46 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 18.42 |
| Current Ratio | 18.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 865.13 |
| Assets | 930.12 |
| Liabilities | 91.25 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 3.30 | -38.53 | |
| 13G/A | Casdin Capital, LLC | 5.99 | 17.30 | |
| 13G/A | Vanguard Group Inc | 8.64 | 2.56 | |
| 13G/A | BlackRock, Inc. | 7.80 | 19.70 | |
| 13G/A | State Street Corp | 3.98 | -21.72 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 210,379 | 994,605 | 21.15 | |
| 163,236 | 1,098,374 | 14.86 | |
| 394,868 | 2,357,298 | 16.75 | |
| 212,493 | 1,707,199 | 12.45 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RANI – Rani Therapeutics Holdings, Inc. | RAPT – RAPT Therapeutics, Inc. |
| RCKT – Rocket Pharmaceuticals, Inc. | RNA – Avidity Biosciences, Inc. |
| RNAC – Cartesian Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io